Higher brain BDNF gene expression is associated with slower cognitive decline in older adults

Neurology

Volumn 86, Issue 8, 2016, Pages 735-741

  Buchman, Aron S ^a,b   Yu, Lei ^a,b   Boyle, Patricia A ^a,b   Schneider, Julie A ^a,b   De Jager, Philip L ^c,d,e   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COGNITION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPAL SCLEROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; NEUROPATHOLOGY; PRIORITY JOURNAL; SEXUAL EDUCATION; VERY ELDERLY; BIOSYNTHESIS; BRAIN; COGNITIVE DEFECT; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; LONGITUDINAL STUDY; METABOLISM; PATHOLOGY;

AGED; AGED, 80 AND OVER; AGING; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 84959254106     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002387     Document Type: Article

References (24)

1. Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med 2011;13:217-222.
2. Forlenza OV, Teixeira AL, Miranda AS, et al. Decreased neurotrophic support is associated with cognitive decline in non-demented subjects. J Alzheimers Dis 2015;46:423-429.
3. Song JH, Yu JT, Tan L. Brain-derived neurotrophic factor in Alzheimer's disease: risk, mechanisms, and therapy. Mol Neurobiol 2014;52:1477-1493.
4. Laske C, Stellos K, Hoffmann N, et al.Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol 2011;14:399-404.
5. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res 2012;9:646-663.
6. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the Religious Orders Study. Curr Alzheimer Res 2012;9:628-645.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
8. Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc 2010;58:248-255.
9. Boyle PA, Yu L, Wilson RS, Segawa E, Buchman AS, Bennett DA. Cognitive decline impairs financial and health literacy among community-based older persons without dementia. Psychol Aging 2013;28:614-624.
10. Bennett DA, Yu L, De Jager PL. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease. Biochem Pharmacol 2014;88:617-630.
11. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011;12:323.
12. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009;10:R25.
13. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007;8:118-127.
14. Shulman JM, Yu L, Buchman AS, et al. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol 2014;71:429-435.
15. Tsai SJ, Hong CJ, Liu HC, Liu TY, Liou YJ. The brainderived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population. Dement Geriatr Cogn Disord 2006;21:139-143.
16. SAS/STAT® User's Guide, version 9.3 [computer Program]. Cary, NC: SAS Institute Inc.; 2011.
17. Yu L, Boyle P, Wilson RS, et al. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology 2012;39: 73-83.
18. Fukumoto N, Fujii T, Combarros O, et al. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2010;153B:235-242.
19. Ciaramella A, Salani F, Bizzoni F, et al. The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients. Brain Behav Immun 2013;32:29-32.
20. Rohe M, Synowitz M, Glass R, Paul SM, Nykjaer A, Willnow TE. Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression. J Neurosci 2009;29:15472-15478.
21. Lin Y, Cheng S, Xie Z, Zhang D. Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer's disease: a meta-analysis. PLoS One 2014;9:e94961.
22. Boyle PA, Buchman AS, Wilson RS, Yu L, Schneider JA, Bennett DA. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry 2012; 69:499-504.
23. Barulli D, Stern Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci 2013;17:502-509.
24. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60: 246-252.